Short Sellers Wary on Major Biotechs
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology and emerging pharmaceuticals. Coming up with a new approach or new way to treat…
These three health care companies included are expected to report their earnings on Tuesday morning.
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
Canada-based marijuana grower Aphria announced Friday morning a strategic investment of C$100 million. The stock is getting beaten up based on a discount of around 6% to Thursday's closing price for the stock.
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
New research shows that several members of the coronavirus family are susceptible to inactivation via a system developed by biomedical products company Cerus.
Applied Genetic Technologies' shares were crushed early on Thursday after the firm reported interim data from its midstage trial in patients with achromatopsia.
Akcea Therapeutics and Ionis Pharmaceuticals each made handy gains on Wednesday after the firms reported midstage results for their cardiovascular disease study.
Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe to severe Alzheimer's disease patients.
Health care giant Johnson & Johnson reported fourth-quarter and full-year 2019 results Wednesday morning. The company posted narrow beats and investors have reacted coolly to guidance.
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was…
For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week.
Rarely does a disease spread fast enough and is labeled dangerous enough that it quickly gets the attention of the WHO. A coronavirus, which has killed several people in China and has spread to…